MedTech News
Medit Launches AuraVue: A Unified 3D Intraoral Scan and X-Ray Visualization Powered by Overjet AI
NEWPORT BEACH, Calif., Dec. 9, 2025 /PRNewswire/ — Medit, a global leader in 3D intraoral scanning and digital dentistry solutions, today announced the launch of AuraVue, a next-generation visualization and consultation platform that integrates Overjet’s AI technology to deliver real-time diagnostic insights and clearer patient communication.
MedINT Launches First Human-in-the-Loop Medical AI Platform for Complex Clinical Decision-Making
TEL AVIV, Israel, Dec. 9, 2025 /PRNewswire/ — MedINT today announced the commercial launch of the first human-in-the-loop medical AI platform designed to return full control of evidence review and treatment decisions to clinicians managing complex patients. The system maintains clinician control at every step by delivering patient-specific evidence summaries that support clinical judgment without replacing it.
Too sick to socialize: How the brain and immune system promote staying in bed
MIT researchers discover how an immune system molecule triggers neurons to shut down social behavior in mice modeling infection.
Medical Microinstruments wins FDA nod for surgical robot instruments
Medical Microinstruments (MMI) announced today that the FDA granted 510(k) clearance for its NanoWrist surgical robot instruments.
Aquapass’s fluid overload therapy system gains marketing approval in Israel
The approval is said to cover a range of clinical indications and supports use in both acute and chronic patients.
Wireless device uses light patterns to deliver information directly to the brain
In a new leap for neurobiology and bioelectronics, Northwestern University scientists have developed a wireless device that uses light to send information directly to the brain—bypassing the body’s natural sensory pathways.
EyeYon Medical Ltd. Receives FDA IDE Approval to Initiate U.S. Clinical Study of EndoArt®, the First Artificial Endothelial Layer for Corneal Edema
NES ZIONA, Israel, Dec. 8, 2025 /PRNewswire/ — EyeYon Medical Ltd., a global leader in ophthalmic innovation, today announced that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to initiate a U.S. clinical study of EndoArt®, the world’s first synthetic endothelial layer for the treatment of chronic corneal edema. EndoArt® is currently designated by the FDA as a Breakthrough Device.
New hepatitis C test paves the way for same-day treatment
15-minute test developed at Northwestern provides results up to 75% faster than current rapid tests